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Introduction 
Coronaviruses (CoVs) are enveloped, crown-like 
viruses [1], composed of a single-stranded ribonucleic 
acid (RNA) genome, able to infect vertebrates. In 
December 2019, a new coronavirus, namedSARS-CoV-
2, emerged in Wuhan, Hubei, China, and caused the 
COVID-19 disease, which has affected millions of lives 
worldwide. The infection sensitizes the upper and lower 
respiratory tract [2], thus, the contagion occurs through 
sneezing and saliva droplets [3,4]. Infected individuals 
show the first symptoms, approximately, five days after 
the incubation period [7-9], and the transmission lasts 
an average of seven days after the onset of symptoms 
[5,6]. As the virus spreads through the air, the best 
methods of prevention are hand disinfection with 
ethanol 70% or soap, use of masks and social 
distancing, and vaccination [5].  
The rapid spread of COVID-19 interferes in the 
daily lives of billions of people on the planet, from the 
social, economic, scientific and medical aspects. The 
pandemic showed, approximately, 214,468,601 
confirmed cases and 4,470,969 deaths as of August 
2021; in South America: 34,633,766 confirmed cases 
and 1,065,582 deaths. Brazil is currently considered one 
of the most important epicenters of the COVID-19 
disease, since from the beginning of the pandemic the 
country has recorded 20,741,815 confirmed cases and 
579,308deaths [10]. 
So far, the SARS-CoV-2 lethality has been mostly 
associated with elderly or immunocompromised patients 
[11]. Nonetheless, pregnant women and postpartum 
women were considered groups of greater clinical 
vulnerability for COVID-19, due to changes in the 
immunity mechanism and greater sensitivity to hypoxia 
[12-14]. This condition is associated with negative 
outcomes, such as hospitalizations and deaths, and 
represents a high risk of transmission to the newborn 
(NB) [15-17]. 
In Brazil, care for infected pregnant women and 
postpartum women is associated with the low 
availability of respirators and intensive care, resulting in 
high numbers of maternal deaths and poor prognosis for 
the NB [18]. Postnatal or horizontal transmission of the 
virus to the NB is more frequent and worsens when the 
mother is symptomatic [19]. However, evidence of 
vertical transmission was observed in a study carried out 
in China.  
Therefore, it is notorious the need for control 
measures and prevention procedures during childbirth 
and puerperium [20]. The wide diversity of 
socioeconomic, climatic and geographic characteristics 
of Brazil are critical to define the profile of the vulnerable 
population to infection. Moreover, the association of 
great economic inequalities, the migratory process to 
big cities and the environmental disorder negatively 
influences the fight against the disease. 
Thus, this study aimed to investigate the main 
epidemiological variables affecting a population of NB 
tested for COVID-19 in Brazil and notified for severe 
acute respiratory syndrome (SARS), from May 2020 to 
June 2021. In addition, to evaluate the frequencies of 
comorbidities associated with the population studied, as 
well as the relationship between symptoms, chronic 
diseases and COVID-19, and to correlate the data on the 
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sociodemographic, clinical and behavioral characteristics 
associated with the condition. 
 
Methods 
Study Design and Development 
This study is retrospective, it analyzed the 
secondary database of the SIVEP influenza (Sistema de 
Informação de Vigilância Epidemiológica, available at. 
https://opendatasus.saude.gov.br/dataset/bd-srag-
2021). 
Data from SIVEP influenza reported as Severe 
Acute Respiratory Syndrome (SARS) in the entire 
national population during the period from May 2020 to 
June 2021 were selected, synthesized in a spreadsheet 
with all fields of the form and considering the cases of 
SARS regardless of hospitalization. The original 
spreadsheet generated by the system showed 
1,646,375 cases notified in this period. 
In this study, the inclusion criteria for data analysis 
were individuals with RT-qPCR positive for COVID-19 
infection notified, which presented from zero to 28 days 
old. Individuals without adequate time for the collection 
of the RT-qPCR laboratory test, and incomplete forms t 




The research followed the rules of the resolution 
466/2012 – CNS/MS and was exempted from the 
evaluation of the Human Research Ethics Committee. 
 
Results and Discussion 
Sistema de Informação de Vigilância 
Epidemiológica of flu (SIVEP) allows the evaluation of 
notifications of infections by COVID-19 throughout the 
national territory. From the initial worksheet, 283 
records of NB were selected, 52.1% of which were 
female and 47.3% were male. Of these NB, 64.9% were 
cured of COVID-19, 19.4% died due to COVID-19 
complications and 1.2% died from other causes. The 
average lifespan was 4.06 days, with a median of 2.00, 
and minimum values of zero days and maximum of 26 
days. 
Regarding the Brazilian regions where the cases of 
COVID-19 occurred, 27 (9.6%) were from the South 
region (nine cases in each of the states); 95 (33.6%) 
were from the Southeast region (being 46 from São 
Paulo, 27 from Minas Gerais, 15 from Rio de Janeiro and 
seven from Espírito Santo); 14 (4.9%) were from the 
Midwest region (four from Goiás, four from Mato 
Grosso,one from Mato Grosso do Sul, and fivefrom the 
Federal District); 137 (48.4%) were from the Northeast 
region (13 from Bahia, one from Maranhão, two from 
Piauí, 74 from Pernambuco, seven from Paraíba,  seven 
from Ceará and 33 from Sergipe); 10 (3.5%) were from 
the North region (five from Amazonas, one from Pará, 
one from Roraima, one from Rondônia, and two from 
Tocantins). 
Many of these newborns showed significant 
symptoms. The presence of fever was identified in 40 
(20.7%) of the patients, while, dyspnea was observed 
in 98 (46.4%). Regarding cough during hospitalization, 
it was reported that 34 (17.9%) patients presented the 
symptom. 
In addition to the symptoms of the patients, a very 
important factor that was analyzed is the stay in the 
Neonatal Intensive Care Units (ICU) during the period of 
infection. The results showed that 161 of the newborns 
were referred to the ICUs (69.7%) and 68 (24.0%) did 
not need to be referred to the Neonatal ICU. 
 
Conclusion 
The analyzed data showed that t the region with 
the most cases in newborns was the Northeast, with 
Pernambuco state presenting the highest number of 
COVID-19 cases in NB, followed by the Southeast region 
(São Paulo state). Some states did not notified cases in 
NB, such as Acre, Amapá and Rio Grande do Norte. The 
marjority of patients were very young, displaying an 
average of 4 days of life, demonstrating that many NB 
had a clinical condition subsequent to birth, inferring a 
probable vertical infection. Despite more than 60% of 
recovery rate for COVID-19, some patients could evolve 
to death due to other secondary diseases. Additionally, 
it was observed that most cases were in female patients 
and that most patients were admitted to the Neonatal 
ICU. Furthermore, this study revealed that many cases, 
despite the difficult diagnosis, had the classic symptoms 
of COVID-19, including fever, dyspnea and cough, being 
identified in a considerable part of the infected cases. 
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